Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    No new stock highs, no problem: Options traders bet they’re coming in these names

    September 22, 2026

    Trump-Zelenskyy meeting: U.S. says Russia lost control of diesel oil

    September 22, 2026

    Putin’s ‘war heroes’ form new political elite in Russian parliament

    September 22, 2026
    Facebook X (Twitter) Instagram
    Addison Markets Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets Addison Markets
    Home»Tech»RFK Jr. won’t back CDC director on vaccines as agency scraps positive data
    Tech

    RFK Jr. won’t back CDC director on vaccines as agency scraps positive data

    franperez66q@protonmail.comBy franperez66q@protonmail.comApril 23, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    Kennedy replied without hesitation: “I’m not going to make that kind of commitment.”

    “Because you probably won’t,” Ruiz said. “You’ll probably fire her, too, like you did director Monarez, because you will not accept the recommendations based on science.”

    Suppressed science

    A report from the Washington Post on Wednesday seemed to support Ruiz’s concern for Kennedy’s continued anti-vaccine interference. The Post reported that the CDC has decided to entirely scrap a scientifically vetted study that identified significant health benefits from the 2025–2026 COVID-19 vaccine. While Kennedy has called COVID-19 vaccines the “deadliest vaccine ever made,” the study found that the shot reduced the risk of emergency department or urgent care visits by 50 percent, and reduced the risk of COVID-19-associated hospitalizations by 55 percent, compared with healthy adults who did not get this season’s shot.

    The study had previously cleared scientific review and was set for publication in the agency’s Morbidity and Mortality Weekly Report on March 19. But the study was instead held up by acting CDC director Jay Bhattacharya, who said he had concerns about the study’s methods. The study used a standard, widely accepted design. A flu vaccine study using the same design was published in the MMWR earlier in March.

    Last month, Andrew Nixon, spokesperson for the Department of Health and Human Services, said that CDC scientists were working to address Bhattacharya’s concerns. But this week, Nixon told the Post that an “editorial assessment identified concerns regarding the methodological approach to estimating vaccine effectiveness and the manuscript was not accepted for publication.”

    The Post’s sources said that was not an accurate account of what happened.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Ukrainian drones overwhelm Russian tanks’ new active protection system—for now

    August 19, 2026

    Jim Cramer says the market is too negative — and that’s creating buying opportunities

    August 19, 2026

    “Sabotage”: Experts, lawmakers blast RFK Jr. for destroying healthcare research

    August 18, 2026

    OpenAI rolls out ChatGPT for Teens with more safety protections

    August 18, 2026

    Against all odds, SpaceX finally tugs Starship into port after 24 days at sea

    August 18, 2026

    Economists warn AI-driven market rally is due a sharp correction

    August 18, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    No new stock highs, no problem: Options traders bet they’re coming in these names

    September 22, 2026

    Trump-Zelenskyy meeting: U.S. says Russia lost control of diesel oil

    September 22, 2026

    Putin’s ‘war heroes’ form new political elite in Russian parliament

    September 22, 2026

    Novo CEO signals M&A opportunities to strengthen drug pipeline

    September 22, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.